Gainers
- Star Equity Hldgs STRR shares increased by 12.15% to $2.86 during Tuesday's after-market session. Trading volume for this security closed at 815.4K, accounting for 520.33% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.6 million.
- ASLAN Pharmaceuticals ASLN shares increased by 8.47% to $1.28. The company's market cap stands at $89.1 million.
- Liquidia LQDA stock moved upwards by 5.66% to $4.48. The market value of their outstanding shares is at $232.8 million.
- TherapeuticsMD TXMD stock moved upwards by 5.61% to $0.41. At the close, TherapeuticsMD's trading volume reached 91.0K shares. This is 1.84% of its average volume over the last 100 days. The market value of their outstanding shares is at $175.0 million.
- Better Therapeutics BTTX stock increased by 4.6% to $5.0. The market value of their outstanding shares is at $117.9 million.
- Biofrontera BFRI stock rose 4.54% to $5.75. The market value of their outstanding shares is at $83.1 million.
Losers
- Pulmatrix PULM stock fell 4.8% to $0.68 during Tuesday's after-market session. The market value of their outstanding shares is at $37.9 million.
- Evoke Pharma EVOK shares decreased by 4.69% to $0.61. The company's market cap stands at $19.9 million.
- iSpecimen ISPC stock decreased by 4.31% to $12.0. The market value of their outstanding shares is at $104.5 million.
- Aytu BioPharma AYTU shares decreased by 4.2% to $1.6. The company's market cap stands at $45.0 million.
- Eyenovia EYEN stock declined by 4.13% to $3.49. The company's market cap stands at $99.1 million.
- Savara SVRA shares decreased by 3.61% to $1.07. The company's market cap stands at $121.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in